Panel Discussion: Prepare for Success - Addressing (and Conquering) the New Economic Realities Facing Emerging Technology and Life Science Businesses
Date & Time/Location: 3-26-09, 1:30pm-3:00pm, Salon D
In this dramatic economic climate, emerging technology and life science companies face challenges to their growth and success that are unlike their predecessors. To survive and to thrive, these companies need to address these challenges with creative, nimble, and unique strategies. This panel focuses on these unique challenges and offers insights into successfully navigating these challenges and forging ahead. The panel members represent some of this region?s most successful entrepreneurs, venture capitalists, angel investors and advisors who have deep experience and a successful track record advising companies in both good and challenging times. The panel members will offer their insights and perspectives on the current funding climate, on how to set priorities and create strategies that will take companies through the tough times, and on how to set the stage for future growth and success. Whether you are heading an emerging technology or life science company, considering investing in one, or advising such a company, this panel presentation will be for you.
Speakers:
- Robert Adams, Managing Partner, NextStage Capital, L.P.
- Robert Fesnak, Managing Partner, Fesnak and Associates, LLP
- Michael Harrington, Chair, Fox Rothschild, Corporate Department
- Jane Hoffer, Former President and CEO, Prescient Applied Intelligence
- Frank McCaney, President and Chief Executive Officer, Nitric BioTherapeutics, Inc
- Jeffrey Snellenburg, Financial Consultant, Chairman, PA Angel Network